Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

THRY vs DSGN vs YELP vs FULC vs ANGI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
THRY
Thryv Holdings, Inc.

Internet Content & Information

Communication ServicesNASDAQ • US
Market Cap$164M
5Y Perf.-83.7%
DSGN
Design Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$881M
5Y Perf.-52.4%
YELP
Yelp Inc.

Internet Content & Information

Communication ServicesNYSE • US
Market Cap$1.69B
5Y Perf.-30.6%
FULC
Fulcrum Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$372M
5Y Perf.-40.5%
ANGI
Angi Inc.

Internet Content & Information

Communication ServicesNASDAQ • US
Market Cap$210M
5Y Perf.-95.5%

THRY vs DSGN vs YELP vs FULC vs ANGI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
THRY logoTHRY
DSGN logoDSGN
YELP logoYELP
FULC logoFULC
ANGI logoANGI
IndustryInternet Content & InformationBiotechnologyInternet Content & InformationBiotechnologyInternet Content & Information
Market Cap$164M$881M$1.69B$372M$210M
Revenue (TTM)$771M$0.00$1.47B$0.00$1.02B
Net Income (TTM)$14M$-70M$139M$-76M$20M
Gross Margin67.8%90.0%91.1%
Operating Margin7.6%12.4%4.8%
Forward P/E18.4x13.6x19.9x
Total Debt$257M$645K$42M$6M$498M
Cash & Equiv.$11M$17M$216M$198M$304M

THRY vs DSGN vs YELP vs FULC vs ANGILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

THRY
DSGN
YELP
FULC
ANGI
StockMar 21May 26Return
Thryv Holdings, Inc. (THRY)10016.3-83.7%
Design Therapeutics… (DSGN)10047.6-52.4%
Yelp Inc. (YELP)10069.4-30.6%
Fulcrum Therapeutic… (FULC)10059.5-40.5%
Angi Inc. (ANGI)1004.5-95.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: THRY vs DSGN vs YELP vs FULC vs ANGI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: YELP leads in 5 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Design Therapeutics, Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
THRY
Thryv Holdings, Inc.
The Communication Services Pick

THRY plays a supporting role in this comparison — it may shine differently against other peers.

Best for: communication services exposure
DSGN
Design Therapeutics, Inc.
The Momentum Pick

DSGN is the #2 pick in this set and the best alternative if momentum is your priority.

  • +323.4% vs THRY's -72.2%
Best for: momentum
YELP
Yelp Inc.
The Income Pick

YELP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.82
  • Rev growth 3.7%, EPS growth 19.1%, 3Y rev CAGR 7.1%
  • 10.2% 10Y total return vs FULC's -49.0%
  • 3.7% revenue growth vs FULC's -100.0%
Best for: income & stability and growth exposure
FULC
Fulcrum Therapeutics, Inc.
The Defensive Pick

FULC is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.40, Low D/E 1.8%, current ratio 27.40x
  • Beta 1.40, current ratio 27.40x
Best for: sleep-well-at-night and defensive
ANGI
Angi Inc.
The Communication Services Pick

Among these 5 stocks, ANGI doesn't own a clear edge in any measured category.

Best for: communication services exposure
See the full category breakdown
CategoryWinnerWhy
GrowthYELP logoYELP3.7% revenue growth vs FULC's -100.0%
ValueYELP logoYELPBetter valuation composite
Quality / MarginsYELP logoYELP9.5% margin vs THRY's 1.9%
Stability / SafetyYELP logoYELPBeta 0.82 vs THRY's 2.31, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)DSGN logoDSGN+323.4% vs THRY's -72.2%
Efficiency (ROA)YELP logoYELP14.1% ROA vs DSGN's -31.3%, ROIC 25.1% vs -28.5%

THRY vs DSGN vs YELP vs FULC vs ANGI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

THRYThryv Holdings, Inc.
FY 2025
Software As A Service
58.7%$461M
Marketing Services
41.3%$324M
DSGNDesign Therapeutics, Inc.

Segment breakdown not available.

YELPYelp Inc.
FY 2025
Advertising
48.7%$1.4B
Advertising, Services
33.2%$948M
Advertising, Restaurants and Other
15.5%$444M
Other Revenue
2.6%$74M
FULCFulcrum Therapeutics, Inc.

Segment breakdown not available.

ANGIAngi Inc.
FY 2025
U.S. Segment
90.5%$43M
International Segment
9.5%$4M

THRY vs DSGN vs YELP vs FULC vs ANGI — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLYELPLAGGINGFULC

Income & Cash Flow (Last 12 Months)

YELP leads this category, winning 4 of 6 comparable metrics.

YELP and FULC operate at a comparable scale, with $1.5B and $0 in trailing revenue. YELP is the more profitable business, keeping 9.5% of every revenue dollar as net income compared to THRY's 1.9%. On growth, YELP holds the edge at +0.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
RevenueTrailing 12 months$771M$0$1.5B$0$1.0B
EBITDAEarnings before interest/tax$86M-$78M$236M-$86M$86M
Net IncomeAfter-tax profit$14M-$70M$139M-$76M$20M
Free Cash FlowCash after capex$68M-$54M$281M-$64M$26M
Gross MarginGross profit ÷ Revenue+67.8%+90.0%+91.1%
Operating MarginEBIT ÷ Revenue+7.6%+12.4%+4.8%
Net MarginNet income ÷ Revenue+1.9%+9.5%+1.9%
FCF MarginFCF ÷ Revenue+8.8%+19.1%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year-7.5%+0.8%-3.2%
EPS Growth (YoY)Latest quarter vs prior year+145.5%+6.5%-16.7%+10.7%-163.3%
YELP leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ANGI leads this category, winning 4 of 6 comparable metrics.

At 5.6x trailing earnings, ANGI trades at a 99% valuation discount to THRY's 539.1x P/E. On an enterprise value basis, ANGI's 3.2x EV/EBITDA is more attractive than YELP's 6.2x.

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
Market CapShares × price$164M$881M$1.7B$372M$210M
Enterprise ValueMkt cap + debt − cash$410M$864M$1.5B$181M$404M
Trailing P/EPrice ÷ TTM EPS539.13x-11.56x12.71x-5.83x5.57x
Forward P/EPrice ÷ next-FY EPS est.18.36x13.61x19.92x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple3.30x6.18x3.22x
Price / SalesMarket cap ÷ Revenue0.21x1.15x0.20x
Price / BookPrice ÷ Book value/share0.76x3.80x2.61x1.25x0.26x
Price / FCFMarket cap ÷ FCF5.28x5.23x4.62x
ANGI leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

YELP leads this category, winning 5 of 9 comparable metrics.

YELP delivers a 19.7% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-33 for DSGN. DSGN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to THRY's 1.18x. On the Piotroski fundamental quality scale (0–9), YELP scores 6/9 vs DSGN's 2/9, reflecting solid financial health.

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
ROE (TTM)Return on equity+6.6%-33.1%+19.7%-27.8%+2.1%
ROA (TTM)Return on assets+2.1%-31.3%+14.1%-26.3%+1.2%
ROICReturn on invested capital+13.6%-28.5%+25.1%-36.2%+5.0%
ROCEReturn on capital employed+16.6%-34.8%+22.9%-28.1%+5.1%
Piotroski ScoreFundamental quality 0–952636
Debt / EquityFinancial leverage1.18x0.00x0.06x0.02x0.54x
Net DebtTotal debt minus cash$246M-$16M-$174M-$191M$194M
Cash & Equiv.Liquid assets$11M$17M$216M$198M$304M
Total DebtShort + long-term debt$257M$645,000$42M$6M$498M
Interest CoverageEBIT ÷ Interest expense2.78x5.38x
YELP leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DSGN and YELP and FULC each lead in 2 of 6 comparable metrics.

A $10,000 investment in YELP five years ago would be worth $7,215 today (with dividends reinvested), compared to $386 for ANGI. Over the past 12 months, DSGN leads with a +323.4% total return vs THRY's -72.2%. The 3-year compound annual growth rate (CAGR) favors FULC at 30.7% vs THRY's -43.4% — a key indicator of consistent wealth creation.

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
YTD ReturnYear-to-date-34.4%+54.9%-5.7%-37.0%-58.6%
1-Year ReturnPast 12 months-72.2%+323.4%-19.9%+35.7%-65.4%
3-Year ReturnCumulative with dividends-81.9%+85.5%+1.6%+123.4%-79.5%
5-Year ReturnCumulative with dividends-86.3%-49.7%-27.9%-34.4%-96.1%
10-Year ReturnCumulative with dividends-57.5%-66.0%+10.2%-49.0%-94.1%
CAGR (3Y)Annualised 3-year return-43.4%+22.9%+0.5%+30.7%-41.1%
Evenly matched — DSGN and YELP and FULC each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DSGN and YELP each lead in 1 of 2 comparable metrics.

YELP is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than THRY's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DSGN currently trades 81.7% from its 52-week high vs THRY's 24.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
Beta (5Y)Sensitivity to S&P 5002.21x1.49x0.77x1.14x1.54x
52-Week HighHighest price in past year$15.49$17.25$41.22$15.74$19.42
52-Week LowLowest price in past year$1.91$3.11$19.60$4.78$4.53
% of 52W HighCurrent price vs 52-week peak+24.0%+81.7%+69.1%+43.7%+27.0%
RSI (14)Momentum oscillator 0–10056.462.357.242.026.1
Avg Volume (50D)Average daily shares traded1.2M377K1.1M990K1.2M
Evenly matched — DSGN and YELP each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: THRY as "Buy", DSGN as "Buy", YELP as "Hold", FULC as "Buy", ANGI as "Hold". Consensus price targets imply 200.4% upside for FULC (target: $21) vs 3.0% for YELP (target: $29).

MetricTHRY logoTHRYThryv Holdings, I…DSGN logoDSGNDesign Therapeuti…YELP logoYELPYelp Inc.FULC logoFULCFulcrum Therapeut…ANGI logoANGIAngi Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyHold
Price TargetConsensus 12-month target$6.50$17.50$29.33$20.67$9.80
# AnalystsCovering analysts67671654
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.0%0.0%+17.3%0.0%+70.7%
Insufficient data to determine a leader in this category.
Key Takeaway

YELP leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ANGI leads in 1 (Valuation Metrics). 2 tied.

Best OverallYelp Inc. (YELP)Leads 2 of 6 categories
Loading custom metrics...

THRY vs DSGN vs YELP vs FULC vs ANGI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is THRY or DSGN or YELP or FULC or ANGI a better buy right now?

For growth investors, Yelp Inc.

(YELP) is the stronger pick with 3. 7% revenue growth year-over-year, versus -100. 0% for Fulcrum Therapeutics, Inc. (FULC). Angi Inc. (ANGI) offers the better valuation at 5. 6x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate Thryv Holdings, Inc. (THRY) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — THRY or DSGN or YELP or FULC or ANGI?

On trailing P/E, Angi Inc.

(ANGI) is the cheapest at 5. 6x versus Thryv Holdings, Inc. at 539. 1x. On forward P/E, Yelp Inc. is actually cheaper at 13. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — THRY or DSGN or YELP or FULC or ANGI?

Over the past 5 years, Yelp Inc.

(YELP) delivered a total return of -27. 9%, compared to -96. 1% for Angi Inc. (ANGI). Over 10 years, the gap is even starker: YELP returned +4. 8% versus ANGI's -93. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — THRY or DSGN or YELP or FULC or ANGI?

By beta (market sensitivity over 5 years), Yelp Inc.

(YELP) is the lower-risk stock at 0. 77β versus Thryv Holdings, Inc. 's 2. 21β — meaning THRY is approximately 188% more volatile than YELP relative to the S&P 500. On balance sheet safety, Design Therapeutics, Inc. (DSGN) carries a lower debt/equity ratio of 0% versus 118% for Thryv Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — THRY or DSGN or YELP or FULC or ANGI?

By revenue growth (latest reported year), Yelp Inc.

(YELP) is pulling ahead at 3. 7% versus -100. 0% for Fulcrum Therapeutics, Inc. (FULC). On earnings-per-share growth, the picture is similar: Thryv Holdings, Inc. grew EPS 100. 3% year-over-year, compared to -637. 5% for Fulcrum Therapeutics, Inc.. Over a 3-year CAGR, YELP leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — THRY or DSGN or YELP or FULC or ANGI?

Yelp Inc.

(YELP) is the more profitable company, earning 9. 9% net margin versus 0. 0% for Fulcrum Therapeutics, Inc. — meaning it keeps 9. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: YELP leads at 12. 6% versus 0. 0% for FULC. At the gross margin level — before operating expenses — ANGI leads at 90. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is THRY or DSGN or YELP or FULC or ANGI more undervalued right now?

On forward earnings alone, Yelp Inc.

(YELP) trades at 13. 6x forward P/E versus 19. 9x for Angi Inc. — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FULC: 200. 4% to $20. 67.

08

Which pays a better dividend — THRY or DSGN or YELP or FULC or ANGI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is THRY or DSGN or YELP or FULC or ANGI better for a retirement portfolio?

For long-horizon retirement investors, Yelp Inc.

(YELP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 77)). Thryv Holdings, Inc. (THRY) carries a higher beta of 2. 21 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (YELP: +4. 8%, THRY: -56. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between THRY and DSGN and YELP and FULC and ANGI?

These companies operate in different sectors (THRY (Communication Services) and DSGN (Healthcare) and YELP (Communication Services) and FULC (Healthcare) and ANGI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: THRY is a small-cap quality compounder stock; DSGN is a small-cap quality compounder stock; YELP is a small-cap deep-value stock; FULC is a small-cap quality compounder stock; ANGI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

THRY

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 40%
Run This Screen
Stocks Like

DSGN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

YELP

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

FULC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ANGI

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.